Components of drugs in acupoint sticking therapy and its mechanism of intervention on bronchial asthma based on UPLC-Q-TOF-MS combined with network pharmacology and experimental verification.
10.19540/j.cnki.cjcmm.20210903.401
- Author:
Jun HU
1
;
Ling WENG
2
;
Cong ZHANG
3
;
Shu-Mei ZHAO
1
;
Kai-Wen GE
1
;
Kuan DI
1
;
Meng CAO
2
;
He-Sheng WANG
3
;
Lin-Gang ZHAO
3
;
Lan-Ying LIU
3
Author Information
1. Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China Nanjing University of Chinese Medicine Nanjing 210023, China.
2. Nanjing University of Chinese Medicine Nanjing 210023, China Jiangsu Province Academy of Traditional Chinese Medicine Nanjing 210028, China.
3. Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China Nanjing University of Chinese Medicine Nanjing 210023, China Jiangsu Province Hospital of Chinese Medicine Nanjing 210029, China.
- Publication Type:Journal Article
- Keywords:
UPLC-Q-TOF-MS;
acupoint sticking therapy;
bronchial asthma;
experimental verification;
network pharmacology
- MeSH:
Acupuncture Points;
Animals;
Asthma/drug therapy*;
Drugs, Chinese Herbal;
Immunity, Innate;
Lymphocytes;
Mice;
Network Pharmacology
- From:
China Journal of Chinese Materia Medica
2022;47(5):1359-1369
- CountryChina
- Language:Chinese
-
Abstract:
UPLC-Q-TOF-MS combined with network pharmacology and experimental verification was used to explore the mechanism of acupoint sticking therapy(AST) in the intervention of bronchial asthma(BA). The chemical components of Sinapis Semen, Cory-dalis Rhizoma, Kansui Radix, Asari Radix et Rhizoma, and Zingiberis Rhizoma Recens were retrieved from TCMSP as self-built database. The active components in AST drugs were analyzed by UPLC-Q-TOF-MS, and the targets were screened out in TCMSP and Swiss-TargetPrediction. Targets of BA were collected from GeneCards, and the intersection of active components and targets was obtained by Venny 2.1.0. The potential targets were imported into STRING and DAVID for PPI, GO, and KEGG analyses. The asthma model induced by house dust mite(HDM) was established in mice. The mechanism of AST on asthmatic mice was explored by pulmonary function, Western blot, and flow cytometry. The results indicated that 54 active components were obtained by UPLC-Q-TOF-MS and 162 potential targets were obtained from the intersection. The first 53 targets were selected as key targets. PPI, GO, and KEGG analyses showed that AST presumedly acted on SRC, PIK3 CA, and other targets through active components such as sinoacutine, sinapic acid, dihydrocapsaicin, and 6-gingerol and regulated PI3 K-AKT, ErbB, chemokine, sphingolipid, and other signaling pathways to intervene in the pathological mechanism of BA. AST can improve lung function, down-regulate the expression of PI3 K and p-AKT proteins in lung tissues, enhance the expression of PETN protein, and reduce the level of type Ⅱ innate immune cells(ILC2 s) in lung tissues of asthmatic mice. In conclusion, AST may inhibit ILC2 s by down-regulating the PI3 K-AKT pathway to relieve asthmatic airway inflammation and reduce airway hyperresponsiveness.
